Ethyl 5-bromo-2-chloropyrimidine-4-carboxylate, 95+%, 1g

beta-D-gentiobiose, min. 98%, for biochemistry, 1 g, glass packaging

Fmoc-3-(2-Naphthyl)-L-alanine, 98.00%, 10g

3-Fluoro-3-methylpiperidin-4-ol hydrochloride, 98%, 1g

Ammonia solution 25%, min. 25%, extra pure, 30 l, plastic packaging.

(Z)-Docos-13-enoic acid, 85.0%, 100g

2-Methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ol, 95.0%, 1g

Sarafloxacin Hydrochloride, >97.0%(HPLC), 5g

1-(tert-Butyl) 2-methyl 3,3-difluoropyrrolidine-1,2-dicarboxylate, 95+%, 100mg

ETHYL (5-CHLOROPYRIDIN-2-YL)ACETATE, 95.0%, 250mg

5-Methoxy-2,2-dimethyl-2H-chromene-6-carbaldehyde, 5g

2-((4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)amino)-2-oxoacetic acid (Neratinib Impurity), 97%, 50mg

(3-Bromo-4-hydroxyphenyl)(isoindolin-2-yl)methanone, 95%, 1g